Casa
asdas

Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor

Por um escritor misterioso

Descrição
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Translating Improvements with Ixekizumab in Clinical Trial
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
An update on serum biomarkers to assess axial spondyloarthritis
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Correlation between change in Bath ankylosing spondylitis disease
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Mean (A) ASDAS and (B) BASDAI up to Week 48. Safety Set (N=89
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Disease Activity Cutoff Values in Initiating Tumor Necrosis Factor
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Biomarkers for Diagnosis of Axial Spondyloarthritis, Disease
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Frontiers The Clinical and MRI Effect of TNF-α Inhibitors in
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Recommendations by the Spanish Society of Rheumatology on the Use
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Genes, Free Full-Text
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Therapeutic potential of TNFα inhibitors in chronic inflammatory
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Frontiers The Clinical and MRI Effect of TNF-α Inhibitors in
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Long-Term Adherence to Etanercept in Treatment Effectiveness of
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
TNF Inhibitor - an overview
de por adulto (o preço varia de acordo com o tamanho do grupo)